Kenvue, the maker of Tylenol and Band-Aid, announced a 4% reduction in its global workforce, totaling 880 layoffs, as part of an efficiency plan to boost competitiveness and expand its key brands. This move coincided with the company's first-quarter financial results, where it surpassed Wall Street's profit estimates. Kenvue reported a Non-GAAP EPS of $0.28, beating expectations by $0.03, and a revenue of $3.9 billion, exceeding forecasts by $110 million. Following the announcement, Kenvue's stock experienced a notable increase, jumping 4.7%.
Kenvue will cut 4% of its global workforce amid investments to grow its key brands, the Tylenol and Band-Aid maker said on Tuesday, as it topped beat Wall Street estimates for first-quarter profit. https://t.co/EiTw2jZ795 https://t.co/EiTw2jZ795
Tylenol maker Kenvue is laying off 880 employees
Kenvue will cut 4% of its global workforce amid investments to grow its key brands, the Tylenol and Band-Aid maker said on Tuesday, as it topped beat Wall Street estimates for first-quarter profit. https://t.co/rwHAC6H2vG https://t.co/rwHAC6H2vG
🇺🇸 Kenvue’s stock jumps 2% after earnings beat https://t.co/c2pI4uRy2r
Tylenol maker Kenvue to cut 4% jobs, beats quarterly profit estimates https://t.co/JYOuEgg3RP
Kenvue shares jump after earnings and disclosure of 4% workforce reduction https://t.co/K5SOcngn6P
Kenvue shares rose after the consumer health company announced plans for a roughly 4% reduction in its global workforce, part of an efficiency plan intended to make it more competitive. https://t.co/0sNexd4CC7
$KVUE (+1.3% pre) Kenvue Non-GAAP EPS of $0.28 beats by $0.03, revenue of $3.9B beats by $110M - SA https://t.co/4MMeJSadCr
Kenvue beat Wall Street estimates for first-quarter profit on Tuesday, and said it would cut 4% of its global workforce amid the Tylenol and Band-Aid maker's efforts to expand its key brands. https://t.co/Ea7Gjmjw6l https://t.co/Ea7Gjmjw6l
Kenvue’s stock jumps 4.7% after earnings beat and news company to cut 4% of global workforce https://t.co/JsePocQe8n